Grifols (FRA:G0F) Cyclically Adjusted PS Ratio: (As of Jul. 29, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:G0F Grifols SA FRA:G0F
82 GF Score
Price €4.62
GF Value €5.09
! 7 Warning Signs
View Full Analysis

What is Grifols Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Grifols  (FRA:G0F) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Grifols Cyclically Adjusted PS Ratio Related Terms


Grifols Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Grifols's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Grifols Cyclically Adjusted PS Ratio Chart

Grifols Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 1.51 1.99 1.09 1.17

Grifols Quarterly Data
Sep20 Dec20 Mar21 Jun21 Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.17 1.38 1.17 0.96 0.00

FRA:G0F vs LLY, JNJ, ABBV: Cyclically Adjusted PS Ratio Comparison

For the Drug Manufacturers - General subindustry, Grifols's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Grifols Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Grifols's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Grifols's Cyclically Adjusted PS Ratio falls into.


FRA:G0F
82GF Score
Grifols SA FRA:G0F
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Grifols Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Grifols's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Grifols's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=1.377/130.5100*130.5100
=1.377

Current CPI (Jun. 2026) = 130.5100.

Grifols Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201509 0.693 99.559 0.908
201512 0.766 100.268 0.997
201603 0.689 98.638 0.912
201606 0.713 100.333 0.927
201609 0.741 99.737 0.970
201612 0.804 101.842 1.030
201703 0.777 100.896 1.005
201706 0.825 101.848 1.057
201709 0.755 101.524 0.971
201712 0.781 102.975 0.990
201803 0.748 102.122 0.956
201806 0.812 104.165 1.017
201809 0.843 103.818 1.060
201812 0.870 104.193 1.090
201903 0.860 103.488 1.085
201906 0.918 104.612 1.145
201909 0.961 103.905 1.207
201912 0.984 105.015 1.223
202003 0.945 103.469 1.192
202006 1.086 104.254 1.360
202009 0.983 103.521 1.239
202012 0.949 104.456 1.186
202103 0.867 104.857 1.079
202106 0.988 107.102 1.204
202112 0.000 111.298 0.000
202206 1.136 118.044 1.256
202209 1.135 117.221 1.264
202212 1.262 117.650 1.400
202306 1.307 120.278 1.418
202309 1.176 121.343 1.265
202312 1.303 121.300 1.402
202406 1.225 124.409 1.285
202409 1.319 123.121 1.398
202412 1.452 124.753 1.519
202503 1.312 125.531 1.364
202506 1.373 127.251 1.408
202509 1.371 126.840 1.411
202512 1.456 128.400 1.480
202603 1.249 129.860 1.255
202606 1.377 130.510 1.377

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Grifols (FRA:G0F) Overvalued in 2026?

Based on GuruFocus' analysis, Grifols stock appears to be undervalued. The current stock price of €4.62 is trading 9.2% below its estimated GF Value™ of €5.09.

Key valuation signals for FRA:G0F:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: €5.09 vs. price of €4.62 (9.2% below fair value)
  • GF Score™: 82/100 with 7 warning signs

No single metric tells the full story. See the FRA:G0F stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Grifols Business Description

Address Avinguda de la Generalitat, 152-158, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, ESP, 08174
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.
82GF Score

Get the complete analysis for FRA:G0F

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.62
Price
€5.09
GF Value